Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: Comparison with the effects of lovastatin and 17β-estradiol

Phytotherapy Research

Volumn 20, Issue 1, 2006, Pages 21-27

  Mukherjee, M ^a   Das, A S ^a   Das, D ^a   Mukherjee, S ^a   Mitra, S ^b   Mitra, Chandan ^a,c  

^a PRESIDENCY UNIVERSITY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c NONE   (India)

Author keywords

17 estradiol; Bone loss; Garlic oil; Lovastatin; Ovariectomy

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; ESTRADIOL; GARLIC OIL; HYDROXYPROLINE; MEVINOLIN; PHOSPHATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFICACY; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PHOSPHATE EXCRETION; POSTMENOPAUSE OSTEOPOROSIS; RAT; TREATMENT OUTCOME;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ALLYL COMPOUNDS; ANIMALS; BONE DENSITY; CALCIUM; CHOLESTEROL; CREATININE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; HUMANS; HYDROXYPROLINE; ISOENZYMES; LOVASTATIN; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHOSPHATES; RATS; RECOVERY OF FUNCTION; SULFIDES;

ALLIUM SATIVUM; ANIMALIA;

EID: 31644445124     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1795     Document Type: Article

References (45)

1. Adeniyi KO, Ogunkeye OO, Isichei CO. 1993. Thyroidectomy and thyroxine administration alter serum calcium levels in rat. Acta Physiol Hung 81: 95-99.
2. Arjmandi BH, Alekel L, Hollis BW et al. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167.
3. Armstrong K, Popik S, Guerra C, Ubel PA. 2000. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Med Decis Making 20: 308-313.
4. Augusti KT, Mathew PT. 1973. Effect of long- term feeding of the aqueous extracts of onion (Allium cepa Linn.) and garlic (Allium sativum Linn.) on normal rats. Indian J Exp Biol 11: 239-241.
5. Bergman I, Loxley R. 1970. The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta 27: 347-349.
6. Branca F, Valtuena S. 2001. The prevention of postmenopausal osteoporosis through phytoestrogen consumption. Ann Nutr Metab 45: 219.
7. Christiansen C, Riis BJ, Rodbro P. 1987. Prediction of rapid bone loss in postmenopausal women. Lancet 1: 1105-1108.
8. Christiansen C, Riss BJ, Rodbro P. 1990. Screening procedure for women at risk of developing post menopausal osteoporosis. Osteoporos Int 1: 35-40.
9. Cummings SR, Black DM, Nevitt MC et al. 1993. Bone density at various sites for prediction of hip fractures. Lancet 341: 72-75.
10. Delmas P. 2002. Treatment of postmenopausal osteoporosis. Lancet 359: 2018-2026.
11. Delmas PU. 1993. Biochemical markers of bone turnover. J Bone Miner Res 8: 5549-5555.
12. Fanelli SL, Castro GD, de Toranzo EG, Castro JA. 1998. Mechanisms of the preventive properties of some garlic components in the carbon tetrachloride-promoted oxidative stress. Diallyl sulfide; diallyl disulfide; allyl mercaptan and allyl methyl sulfide. Res Commun Mol Pathol Pharmacol 102: 163-174.
13. Fisher JE, Rogers MJ, Halasy JM et al. 1999. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96: 133-138.
14. Gert BJ, Shao P, Hanson UA. 1994. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 9: 135-142.
15. Ghosh MN. 1984. Toxicity studies. In Fundamentals of Experimental Pharmacology, 2nd edn. Scientific Book Agency: Calcutta, 155.
16. Gupta NK. 1996. Modification of radiation-induced changes in murine hepatic lipid profiles by garlic (Allium sativum Linn.) unsaturated oils. Indian J Exp Biol 34: 851-853.
17. Halleen JM, Raisanen SR, Alatalo SL, Vaananen HK. 2003. Potential function for the ROS-generating activity of TRACP. J Bone Miner Res 18: 1908-1911.
18. Hansen MA, Overgaard K, Riis BJ, Christiansen C. 1991. Role of peak bone mass and bone loss in postmenopausal osteoporosis. 12 year study. Br Med J 303: 961-964.
19. Holick MF, Krane SM, Jr Potts JT., 1998. Calcium, phosphorus and bone metabolism: calcium regulating hormones. In Harrison's Principles of Internal Medicine, Fauci SA, Braunwald E, Isselbacher KI et al. (eds), Vol. 2, 14th edn. McGraw Hill: Singapore, 2217.
20. Horn-Ross PL, Barnes S, Lee M et al. 2000. Assessing phytoetrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 11: 289-298.
21. http://www.findarticles.com/cf_0/m3374/mag.jhtml.
22. Hui SL, Slemenda CW, Johnston CC. 1990. The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1: 30-34.
23. Kalu DN. 1991. Ovariectomized rat model of post menopausal bone loss. Bone Miner 15: 175-192.
24. Kalu DN, Liu CC, Salerno E, Hollis BW, Echon R, Ray M. 1991. Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14: 175-187.
25. Li X, Cui Q, Kao C, Wang, GJ, Balian G. 2003. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33: 652-659.
26. Li XX, Hara I, Matsumiya T. 2002. Effects of osthole on postmenopausal osteoporosis using ovariectomized rats: Comparison to the effects of estradiol. Biol Pharm Bull 25: 738-742.
27. Lindsay R, Courts JRT, Hart DM. 1977. The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women. Clin Endocrinol 6: 87-93.
28. Lowry HO, Lopez AJ. 1946. The determination of inorganic phosphate in the presence of labile phosphate esters. J Biol Chem 162: 421-428.
29. Maeda T, Matsunuma A, Kawane T, Horiuchi N. 2001. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 280: 874-877.
30. Mathew BC, Daniel RS, Augusti KT. 1996. Hypolipidemic effect of garlic protein substituted for casein in diet of rats compared to those of garlic oil. Indian J Exp Biol 34: 337-340.
31. Mitchell RH, Karnovsky MJ, Karnovsky MF. 1970. The distribution of some granule associated enzyme in guinea pig polymorphonuclear leucocytes. Biochem J 116: 207-216.
32. Mukherjee M, Das AS, Mitra S, Mitra C. 2004. Prevention of bone loss by oil extract of garlic (Allium sativum Linn) in an ovariectomized rat model of osteoporosis. Phytother Res 18: 389-394.
33. Mundy G, Garrett R, Harris S et al. 1999. Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946-1949.
34. Mundy GR. 1996. Osteoporosis into the year 2010. Br J Obstet Gynaecol 103: 32-38.
35. Myburgh KH, Noakes TD, Roodt M, Hough FS. 1989. Effect of exercise on the development of osteoporosis in adult rats. J Appl Physiol 66: 14-19.
36. Nath RL, Nath RK. 1990a. Techniques in the biochemical investigation of diseases. In Practical Biochemistry in Clinical Medicine, 2nd edn. Academic Publishers: Calcutta, 8.
37. Nath RL, Nath RK. 1990b. Tests for renal function - investigation of nephrotic syndrome and other primary organ related disorders. In Practical Biochemistry in Clinical Medicine, 2nd edn. Academic Publishers: Calcutta, 94.
38. Nordin BEC, Horsman A, Aaron J, Gallagher JC. 1975. Post menopausal bone loss. Curr Med Res Opin 3: 28-36.
39. Riis BJ. 1996. The role of bone turnover in the pathophysiology of osteoporosis. Br J Obstet Gynecol 103: 9-15.
40. Sodimu O, Joseph PK, Augusti KT. 1984. Certain biochemical effects of garlic oil on rats maintained on high fat-high cholesterol diet. Experientia 40: 78-80.
41. Stepan JJ. 1999. Enzyme tests in bone disease. In Enzyme Tests in Diagnosis, Moss DW, Rosalki SB (eds). Arnold: London, 162-163.
42. Tripathi KD. 2003. Hypolipidemic drugs and plasma expanders In Essentials of Medical Pharmacology, 5th edn. JB Medical Publishers (P) Ltd: New Delhi, 578.
43. Vaes G. 1988. Cellular biology and biochemical mechanism of bone resorption. Clin Orthop 231: 239-271.
44. Woo JT, Kasai S, Stern PH, Nagai K. 2000. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res 15: 650-662.
45. Yeh JK, Liu CC, Aloia JF. 1993. Effects of exercise and immobilization on bone formation and resorption in young rats. Am J Physiol (Endocrinol. Metab. 27) 264: E182-E189.